Biotech Recruiting Technical Review 
N2Growth Blog
OCTOBER 23, 2023
As the sector evolves and expands, companies increasingly turn to executive search firms like N2Growth to help them identify and recruit top talent for critical leadership roles. The life sciences industry is known for its unique challenges in recruiting and hiring.
TechCrunch
MARCH 21, 2023
When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?
N2Growth Blog
DECEMBER 12, 2024
At N2Growth, we approach the healthcare leadership market with a nuanced lens, drawing on decades of industry experience to ensure that leaders possess the necessary technical expertise and the resilience, strategic insight, and emotional intelligence essential for inspiring teams and shaping the future of patient care.
CIO
SEPTEMBER 18, 2023
When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligent virtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.
TechCrunch
DECEMBER 17, 2022
OK, with that, here’s what I think will happen next year: the return to in-person, five-day work weeks for tech workers. Then, this year, the Great Resignation became the Great Reset, as employers fired large percentages of their staff due to changing macroeconomic conditions. The impact of hype with Clubhouse’s Paul Davison.
TechCrunch
MARCH 23, 2021
Meatable has a long road ahead of it, because, as Gates acknowledged in his interview with MIT Technology Review (ed. These products don’t get at the full potential for cellular technology according to Daan Luining, Meatable’s chief technology officer. ” For Meatable right now, price remains an issue.
TechCrunch
SEPTEMBER 7, 2021
a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. A 2020 review paper in Bioengineering notes the organ-on-a-chip industry was recently valued around $21 million, but could grow to about $220 million by 2025. . Emulate Inc.,
Expert insights. Personalized for you.
178 
Let's personalize your content